sözaltı news Finance
Finance
EN AZ
Could Ionis Pharmaceuticals (IONS) Stock Become a Biotech Powerhouse as its Commercial Pipeline Takes Off?

Could Ionis Pharmaceuticals (IONS) Stock Become a Biotech Powerhouse as its Commercial Pipeline Takes Off?

finance.yahoo.com 29.08.2026 00:05 51 views
Similar stories 1 outlet
Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating? finance.yahoo.com 29.08.2026
Related stories
Michigan feud threatens Democratic unity in key Senate race
Michigan feud threatens Democratic unity in key Senate race
ft.com · 01.11
 Tusk vows to press on with overhaul of Poland’s judiciary
Tusk vows to press on with overhaul of Poland’s judiciary
ft.com · 31.10
 Evacuees from Russian-occupied city arrive in Ukraine
Evacuees from Russian-occupied city arrive in Ukraine
ft.com · 31.10
 Your stock portfolio increasingly hinges on the bond market — and the midterm elections
Your stock portfolio increasingly hinges on the bond market — and the midterm elections
marketwatch.com · 31.10
 Investors trim growth bets over fears of US economy’s AI exposure
Investors trim growth bets over fears of US economy’s AI exposure
ft.com · 31.10
 Iran warns it will retaliate without ‘geographical limitations’ if attacked
Iran warns it will retaliate without ‘geographical limitations’ if attacked
ft.com · 31.10